S&P 500   3,242.82 (-2.84%)
DOW   28,121.91 (-3.00%)
QQQ   222.92 (-3.19%)
AAPL   301.40 (-3.72%)
FB   200.50 (-4.61%)
MSFT   172.94 (-3.16%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,010.73 (-4.07%)
CGC   20.33 (-7.09%)
NVDA   276.45 (-5.99%)
BABA   205.73 (-3.23%)
TSLA   840.37 (-6.73%)
AMD   49.89 (-6.36%)
ACB   1.55 (-7.19%)
F   7.63 (-3.30%)
NFLX   370.78 (-2.44%)
BAC   32.81 (-4.51%)
S&P 500   3,242.82 (-2.84%)
DOW   28,121.91 (-3.00%)
QQQ   222.92 (-3.19%)
AAPL   301.40 (-3.72%)
FB   200.50 (-4.61%)
MSFT   172.94 (-3.16%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,010.73 (-4.07%)
CGC   20.33 (-7.09%)
NVDA   276.45 (-5.99%)
BABA   205.73 (-3.23%)
TSLA   840.37 (-6.73%)
AMD   49.89 (-6.36%)
ACB   1.55 (-7.19%)
F   7.63 (-3.30%)
NFLX   370.78 (-2.44%)
BAC   32.81 (-4.51%)
S&P 500   3,242.82 (-2.84%)
DOW   28,121.91 (-3.00%)
QQQ   222.92 (-3.19%)
AAPL   301.40 (-3.72%)
FB   200.50 (-4.61%)
MSFT   172.94 (-3.16%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,010.73 (-4.07%)
CGC   20.33 (-7.09%)
NVDA   276.45 (-5.99%)
BABA   205.73 (-3.23%)
TSLA   840.37 (-6.73%)
AMD   49.89 (-6.36%)
ACB   1.55 (-7.19%)
F   7.63 (-3.30%)
NFLX   370.78 (-2.44%)
BAC   32.81 (-4.51%)
S&P 500   3,242.82 (-2.84%)
DOW   28,121.91 (-3.00%)
QQQ   222.92 (-3.19%)
AAPL   301.40 (-3.72%)
FB   200.50 (-4.61%)
MSFT   172.94 (-3.16%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,010.73 (-4.07%)
CGC   20.33 (-7.09%)
NVDA   276.45 (-5.99%)
BABA   205.73 (-3.23%)
TSLA   840.37 (-6.73%)
AMD   49.89 (-6.36%)
ACB   1.55 (-7.19%)
F   7.63 (-3.30%)
NFLX   370.78 (-2.44%)
BAC   32.81 (-4.51%)
Log in

OTCMKTS:ZIVO - Zivo Bioscience Stock Price, Forecast & News

$0.17
+0.01 (+6.27 %)
(As of 02/24/2020 03:42 PM ET)
Today's Range
$0.15
Now: $0.17
$0.17
50-Day Range
$0.15
MA: $0.16
$0.17
52-Week Range
$0.04
Now: $0.17
$0.18
Volume103,866 shs
Average Volume90,057 shs
Market Capitalization$59.68 million
P/E RatioN/A
Dividend YieldN/A
Beta1.23
Zivo Bioscience, Inc., together with its subsidiaries, develops natural bioactive ingredients derived from its proprietary algal cultures. The company focuses on licensing and selling its natural bioactive ingredients to animal, human and dietary supplement, and medical food manufacturers; and license its bioactive molecules as lead compounds or templates for synthetic variants intended for therapeutic applications. It is also involved in developing, manufacturing, marketing, and selling tests that allow individuals to optimize their health and identify future health risks, as well as provides insurers, employers, and healthcare providers with timely information to intervene with wellness programs, fitness regimes, or other preventative measures. The company was formerly known as Health Enhancement Products, Inc. and changed its name to Zivo Bioscience, Inc. in November 2014. Zivo Bioscience, Inc. is headquartered in Keego Harbor, Michigan.

Industry, Sector and Symbol

Industry Food & kindred products
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ZIVO
Previous SymbolOTCMKTS:HEPI
CUSIPN/A
CIKN/A
Phone248-452-9866

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.13) per share

Profitability

Net Income$-14,630,000.00

Miscellaneous

Employees4
Market Cap$59.68 million
Next Earnings Date2/25/2020 (Estimated)
OptionableNot Optionable

Receive ZIVO News and Ratings via Email

Sign-up to receive the latest news and ratings for ZIVO and its competitors with MarketBeat's FREE daily newsletter.


Zivo Bioscience (OTCMKTS:ZIVO) Frequently Asked Questions

What is Zivo Bioscience's stock symbol?

Zivo Bioscience trades on the OTCMKTS under the ticker symbol "ZIVO."

When is Zivo Bioscience's next earnings date?

Zivo Bioscience is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Zivo Bioscience.

Has Zivo Bioscience been receiving favorable news coverage?

News articles about ZIVO stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Zivo Bioscience earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Zivo Bioscience.

Who are some of Zivo Bioscience's key competitors?

What other stocks do shareholders of Zivo Bioscience own?

Who are Zivo Bioscience's key executives?

Zivo Bioscience's management team includes the folowing people:
  • Mr. Philip M. Rice II, Chairman, Chief Accounting Officer & CFO (Age 64)
  • Mr. Andrew A. Dahl, Pres & CEO (Age 65)
  • Mr. Ronald C. Costephens, VP of Global Operations
  • Dr. Scott M. Freeman M.D., Chief Science Officer (Age 62)

How do I buy shares of Zivo Bioscience?

Shares of ZIVO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Zivo Bioscience's stock price today?

One share of ZIVO stock can currently be purchased for approximately $0.17.

How big of a company is Zivo Bioscience?

Zivo Bioscience has a market capitalization of $59.68 million. Zivo Bioscience employs 4 workers across the globe.View Additional Information About Zivo Bioscience.

What is Zivo Bioscience's official website?

The official website for Zivo Bioscience is http://www.zivobioscience.com/.

How can I contact Zivo Bioscience?

Zivo Bioscience's mailing address is 2804 ORCHARD LAKE ROAD SUITE 202, KEEGO HARBOR MI, 48320. The biotechnology company can be reached via phone at 248-452-9866 or via email at [email protected]


MarketBeat Community Rating for Zivo Bioscience (OTCMKTS ZIVO)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  93 (Vote Outperform)
Underperform Votes:  120 (Vote Underperform)
Total Votes:  213
MarketBeat's community ratings are surveys of what our community members think about Zivo Bioscience and other stocks. Vote "Outperform" if you believe ZIVO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZIVO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Featured Article: What are no-load funds?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel